Stock 4594 BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BrightPath Biotherapeutics Co., Ltd.

Equities

4594

JP3274140007

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
60 JPY -3.23% Intraday chart for BrightPath Biotherapeutics Co., Ltd. +3.45% -31.03%
2023 BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited CI
2023 BrightPath Biotherapeutics Co., Ltd. announced that it expects to receive ¥5.1678 million in funding from Macquarie Group Limited CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BrightPath Biotherapeutics : Presents Preclinical Data on a CD73 antagonist antibody at AACR 2022
PU
BrightPath Biotherapeutics : Presents New Data on Personalized Neoantigen Vaccine at AACR 2022
PU
BrightPath Biotherapeutics : Presents New Data on Preclinical Data on BP2301(HER2 CAR-T) at AACR 2022
PU
BrightPath Biotherapeutics : Presents New Data on Personalized Neoantigen Vaccine at AACR 2022
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4594 Stock
  4. News BrightPath Biotherapeutics Co., Ltd.
  5. Press Releases